{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreieepia2ikewzrovzq4p4om3cgdb7ayu3nbigsls6gepl2o4jjn4ji",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mndtzg7f3r62"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreied42iroyvscfpoprsovmkubcrkjy7sgd24j7u7d5rqx4stitonce"
    },
    "mimeType": "image/jpeg",
    "size": 188484
  },
  "path": "/news/2026-06-glp-agonists-linked-significantly-term.html",
  "publishedAt": "2026-06-02T18:30:02.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "GLP-1 receptor agonist drugs, used for the treatment of diabetes—and more recently, weight loss—are associated with a significantly lower long-term risk of knee replacement surgery as a result of osteoarthritis, finds an analysis of medical records data, published in the open-access journal Regional Anesthesia & Pain Medicine.",
  "title": "GLP-1 agonists linked to significantly lower long-term risk of knee replacement"
}